LCM
KRTX

Landscape Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Landscape Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,220
Closed -$222K – 769
2023
Q1 		$222K Buy
+1,220
New +$233K 0.03% 409

Other funds holding KRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Landscape Capital Management's KRTX Position: Q2 2023 in Review

Landscape Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q2 2023, closing a stake of 1,220 shares — an estimated $222K sold.

Landscape Capital Management first reported a position in KRTX in Q1 2023 and held it in 1 quarter. The position peaked at $222K in Q1 2023. 289 funds tracked by Wall St. Rank hold KRTX as of Q2 2023.

  • Landscape Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Landscape Capital Management sold 1,220 Karuna Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $222K.
  • Landscape Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Landscape Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $222K in Q1 2023.
  • 289 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Landscape Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.